ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
바이오컨버전스 시장 규모는 향후 몇 년 동안 빠르게 성장할 것으로 예상되며, 2029년에는 11.1%의 CAGR로 2,435억 3,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 재생의료 응용 분야 확대, 만성질환 유병률 증가, 바이오전자 및 바이오센서 채택 확대, 인공 생체재료 개발, 생명공학 연구개발에 대한 투자 급증에 기인할 것으로 보입니다. 주요 동향으로는 신약개발에 인공지능의 통합, 랩온칩 기술의 발전, 웨어러블 바이오센서의 성장, 3D 바이오프린팅의 활용 확대, 표적치료에 나노로봇공학의 활용, 장기온칩 모델의 채택, 유전자 편집 기술의 발전 등을 들 수 있습니다.
개인맞춤의료에 대한 관심이 높아지면서 바이오컨버전스 시장의 성장이 가속화될 것으로 예상됩니다. 맞춤의료는 치료 결과를 최적화하고 치료를 강화하기 위해 환자 개개인의 유전적, 환경적, 생활습관적 요인에 따라 치료를 맞춤화하는 것을 포함합니다. 유전체 기술의 발전으로 유전자 변이를 보다 정확하게 파악할 수 있게 되어 개인별 맞춤 치료가 가능해짐에 따라 맞춤형 의료에 대한 수요가 증가하고 있습니다. 바이오컨버전스는 첨단 기술과 생물학적 연구를 통합하여 환자의 유전적, 분자적 프로파일을 기반으로 보다 정확하고 맞춤화된 치료 계획을 수립할 수 있도록 맞춤형 의료를 지원합니다. 이러한 접근 방식은 표적 치료를 용이하게 하고 부작용을 최소화하여 의료 성과를 향상시킬 수 있습니다. 예를 들어, 2024년 2월 미국 비영리단체인 개인맞춤의료연합(PMC)은 미국 식품의약국(FDA)이 2023년 26개의 맞춤형 신약을 승인했다고 보고했습니다. 그 결과, 개인맞춤의료에 대한 관심이 높아지면서 바이오컨버전스 시장 확대가 가속화되고 있습니다.
바이오컨버전스 시장의 주요 기업들은 자동화된 소형화 단일 세포 단백질체학 샘플 조제와 같은 혁신적인 제품 개발에 주력하고 있으며, 정밀한 단백질 분석을 가능하게 하고, 샘플 손실을 최소화하며, 단일 세포 연구의 워크플로우를 간소화합니다. 자동화된 소형화 단일 세포 단백질체학 샘플 조제는 초미량의 개별 세포로부터의 단백질 취급 및 준비를 자동화하는 과정입니다. 예를 들어, 2022년 9월 독일에 본사를 둔 생명공학 기업 Scienion GmbH는 질량 분석 기반 단일 세포 단백질체학 분석을 위한 재현성 높은 소형화된 워크플로우를 촉진하는 Proteochip LF 48을 발표했습니다. 이 첨단 바이오컨버전스 도구는 개별 세포의 온칩 용해 및 단백질 소화를 가능하게 하여 연구자들이 시료 손실을 줄이고, 워크플로우를 간소화하며, 효율적인 질량 분석을 통해 더 깊은 생물학적 인사이트를 얻을 수 있도록 돕습니다. 정확한 세포 처리와 온칩 라이싱 및 단백질 소화를 결합하여 다양한 단일 세포 단백질체학 애플리케이션에 효과적인 시료 전처리를 제공하여 궁극적으로 워크플로우의 효율성과 데이터 품질을 향상시킵니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 바이오컨버전스 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
최종 이용 산업 분석
세계의 바이오컨버전스 시장 : 성장률 분석
세계의 바이오컨버전스 시장 실적 : 규모와 성장, 2019-2024년
세계의 바이오컨버전스 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 바이오컨버전스 전체 시장(TAM)
제6장 시장 세분화
세계의 바이오컨버전스 시장 : 구성요소별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
디바이스
소프트웨어
서비스
플랫폼
세계의 바이오컨버전스 시장 : 기술별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
인공지능
로봇공학
3D 프린팅
나노기술
합성생물학
바이오인포매틱스
웨어러블 디바이스
세계의 바이오컨버전스 시장 : 용도별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
Drug Discovery
재생의료
광유전학
Drug Discovery를 위한 나노로보틱스
진단 및 생물학적 센서
바이오일렉트로닉스
정밀의료
세계의 바이오컨버전스 시장 : 최종사용자별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
제약·바이오테크놀러지 업계
계약 연구기관
기타
세계의 바이오컨버전스 시장 : 디바이스 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
진단 장비
치료 기기
웨어러블 의료기기
이식형 디바이스
로봇 수술 시스템
세계의 바이오컨버전스 시장 : 소프트웨어 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
바이오인포매틱스 소프트웨어
임상의사결정지원시스템
유전체 데이터 분석 툴
영상 진단 소프트웨어
검사 정보 관리 시스템(LIMS)
세계의 바이오컨버전스 시장 : 서비스 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
계약 연구 서비스
컨설팅 및 통합 서비스
데이터 관리 및 분석 서비스
커스텀 소프트웨어 개발
규제 및 컴플라이언스 서비스
세계의 바이오컨버전스 시장 : 플랫폼 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
인공지능 플랫폼
오믹스 통합 플랫폼
디지털 헬스 플랫폼
맞춤형 의료 플랫폼
클라우드 기반 분석 플랫폼
제7장 지역별·국가별 분석
세계의 바이오컨버전스 시장 : 지역별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 바이오컨버전스 시장 : 국가별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
바이오컨버전스 시장 : 경쟁 구도
바이오컨버전스 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
Veolia Environnement S.A Overview, Products and Services, Strategy and Financial Analysis
Novartis AG Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Eli Lilly and Company
Amgen Inc.
HDR Inc.
Ginkgo Bioworks
BICO Group AB
MeMed Diagnostics Ltd.
Anima Biotech
Singota Solutions LLC
SetPoint Medical Corporation
Galvani Bioelectronics
Ezassi Inc.
Tissue Dynamics Ltd.
Sanara Ventures Ltd.
BioConvergent Health LLC
Gradiant Bioconvergence Center
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
바이오컨버전스 시장 2029년 : 새로운 기회를 제공하는 국가
바이오컨버전스 시장 2029년 : 새로운 기회를 제공하는 부문
바이오컨버전스 시장 2029년 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Bioconvergence is the integration of biology with engineering, data science, and advanced technologies to drive innovation in healthcare, biotechnology, and life sciences. The main objective of bioconvergence is to develop smarter, more personalized, and more efficient solutions such as precision medicine, advanced diagnostics, and bioengineered products. It enables the creation of faster, more cost-effective, and more impactful therapies, devices, and platforms.
The primary components of bioconvergence include devices, software, services, and platforms. Devices refer to hardware or tools that interact with biological systems, combining biology, engineering, and digital technology. This integration involves various advanced technologies such as artificial intelligence, robotics, 3D printing, nanotechnology, synthetic biology, bioinformatics, and wearable devices. These technologies support a wide range of applications, including drug discovery, regenerative medicine, optogenetics, nanorobotics for targeted therapies, diagnostic and biosensing tools, bioelectronics, and precision medicine. Key end users of these innovations include pharmaceutical and biotechnology companies, contract research organizations, and other stakeholders in the healthcare and life sciences industries.
The bioconvergence market research report is one of a series of new reports from The Business Research Company that provides bioconvergence market statistics, including bioconvergence industry global market size, regional shares, competitors with a bioconvergence market share, detailed bioconvergence market segments, market trends and opportunities, and any further data you may need to thrive in the bioconvergence industry. This bioconvergence market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The bioconvergence market size has grown rapidly in recent years. It will grow from $143.20 billion in 2024 to $159.66 billion in 2025 at a compound annual growth rate (CAGR) of 11.5%. The growth during the historic period can be attributed to the rise of personalized medicine, advancements in biomedical engineering, increasing healthcare digitization, the development of bioinformatics, and the collaboration between technology and biotechnology industries.
The bioconvergence market size is expected to see rapid growth in the next few years. It will grow to $243.53 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to the expansion of regenerative medicine applications, rising prevalence of chronic diseases, increased adoption of bioelectronics and biosensors, development of engineered living materials, and a surge in investment in biotechnology research and development. Major trends include the integration of artificial intelligence in drug discovery, advancements in lab-on-a-chip technologies, the growth of wearable biosensors, the expansion of 3D bioprinting applications, the use of nanorobotics for targeted therapies, the adoption of organ-on-a-chip models, and progress in gene editing techniques.
The increasing emphasis on personalized medicine is expected to accelerate the growth of the bioconvergence market. Personalized medicine involves customizing treatments for individual patients based on their genetic, environmental, and lifestyle factors to optimize outcomes and enhance care. The demand for personalized medicine is rising as genomic technologies advance, allowing for more accurate identification of genetic variations and enabling tailored treatments for individuals. Bioconvergence supports personalized medicine by integrating cutting-edge technologies with biological research, allowing for more precise, individualized treatment plans based on a patient's genetic and molecular profile. This approach improves healthcare outcomes by facilitating targeted therapies and minimizing adverse effects. For example, in February 2024, the Personalized Medicine Coalition (PMC), a U.S.-based nonprofit organization, reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, marking a significant increase from the 12 approved in 2022. Consequently, the growing focus on personalized medicine is driving the bioconvergence market's expansion.
Leading companies in the bioconvergence market are focusing on the development of innovative products, such as automated miniaturized single-cell proteomics sample preparation, to enable precise protein analysis, minimize sample loss, and streamline workflows in single-cell research. Automated miniaturized single-cell proteomics sample preparation is a process that automates the handling and preparation of proteins from individual cells in ultra-low volumes. For instance, in September 2022, Scienion GmbH, a biotechnology company based in Germany, introduced the Proteochip LF 48, which facilitates reproducible and miniaturized workflows for mass spectrometry-based single-cell proteomics analysis. This advanced bioconvergence tool enables on-chip lysis and protein digestion of individual cells, helping researchers reduce sample loss, simplify workflows, and gain deeper biological insights through efficient mass spectrometry analysis. The Proteochip LF 48 is highly adaptable, offering effective sample preparation for a wide range of single-cell proteomics applications by combining precise cell handling with on-chip lysis and protein digestion, ultimately enhancing workflow efficiency and data quality.
In May 2022, BICO Group AB, a biotechnology company based in Sweden, acquired Allegro 3D Inc. for an undisclosed amount. This acquisition strengthens BICO's bioconvergence portfolio by integrating Allegro 3D's digital light processing (DLP) technology, which enables high-speed, precise bioprinting for regenerative medicine and drug testing, while also supporting scalable, animal-free tissue development. Allegro 3D Inc., based in the U.S., specializes in DLP bioprinting technology and contributes to bioconvergence through its high-precision tissue engineering and drug testing solutions.
Major players in the bioconvergence market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Veolia Environnement S.A, Novartis AG, Eli Lilly and Company, Amgen Inc., HDR Inc., Ginkgo Bioworks, BICO Group AB, MeMed Diagnostics Ltd., Anima Biotech, Singota Solutions LLC, SetPoint Medical Corporation, Galvani Bioelectronics, Ezassi Inc., Tissue Dynamics Ltd., Sanara Ventures Ltd., BioConvergent Health LLC, Gradiant Bioconvergence Center.
North America was the largest region in the bioconvergence market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the Bioconvergence market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The bioconvergence market consists of revenues earned by entities by providing services such as personalized medicine development, biomedical data analysis, bioinformatics platforms, regenerative medicine solutions, diagnostic technology integration, and smart medical device engineering. The market value includes the value of related goods sold by the service provider or included within the service offering. The bioconvergence market also includes sales of bioprinted tissues and organs, lab-on-a-chip devices, smart implants, bioengineered materials, and integrated diagnostic tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Bioconvergence Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on bioconvergence market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for bioconvergence ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bioconvergence market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Component: Devices; Software; Services; Platforms
3) By Application: Drug Discovery; Regenerative Medicine; Optogenetics; Nanorobotics For Drug Discovery; Diagnostic And Biological Sensors; Bioelectronics; Precision Medicine
4) By End-User: Pharmaceutical And Biotechnology Industry; Contract Research Organization; Other End Users
Subsegments:
1) By Devices: Diagnostic Devices; Therapeutic Devices; Wearable Medical Devices; Implantable Devices; Robotic Surgical Systems
2) By Software: Bioinformatics Software; Clinical Decision Support Systems; Genomic Data Analysis Tools; Imaging And Diagnostic Software; Laboratory Information Management Systems (LIMS)
3) By Services: Contract Research Services; Consulting And Integration Services; Data Management And Analysis Services; Custom Software Development; Regulatory And Compliance Services
4) By Platforms: Artificial Intelligence Platforms; Omics Integration Platforms; Digital Health Platforms; Personalized Medicine Platforms; Cloud-Based Analytics Platforms
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; Veolia Environnement S.A; Novartis AG
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Bioconvergence Market Characteristics
3. Bioconvergence Market Trends And Strategies
4. Bioconvergence Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Bioconvergence Growth Analysis And Strategic Analysis Framework
5.1. Global Bioconvergence PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Bioconvergence Market Growth Rate Analysis
5.4. Global Bioconvergence Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Bioconvergence Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Bioconvergence Total Addressable Market (TAM)
6. Bioconvergence Market Segmentation
6.1. Global Bioconvergence Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Devices
Software
Services
Platforms
6.2. Global Bioconvergence Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Artificial Intelligence
Robotics
Three-Dimensional (3D) Printing
Nanotechnology
Synthetic Biology
Bioinformatics
Wearable Devices
6.3. Global Bioconvergence Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug Discovery
Regenerative Medicine
Optogenetics
Nanorobotics For Drug Discovery
Diagnostic And Biological Sensors
Bioelectronics
Precision Medicine
6.4. Global Bioconvergence Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical And Biotechnology Industry
Contract Research Organization
Other End Users
6.5. Global Bioconvergence Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostic Devices
Therapeutic Devices
Wearable Medical Devices
Implantable Devices
Robotic Surgical Systems
6.6. Global Bioconvergence Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bioinformatics Software
Clinical Decision Support Systems
Genomic Data Analysis Tools
Imaging and Diagnostic Software
Laboratory Information Management Systems (LIMS)
6.7. Global Bioconvergence Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Contract Research Services
Consulting and Integration Services
Data Management and Analysis Services
Custom Software Development
Regulatory and Compliance Services
6.8. Global Bioconvergence Market, Sub-Segmentation Of Platforms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Artificial Intelligence Platforms
Omics Integration Platforms
Digital Health Platforms
Personalized Medicine Platforms
Cloud-Based Analytics Platforms
7. Bioconvergence Market Regional And Country Analysis
7.1. Global Bioconvergence Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Bioconvergence Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Bioconvergence Market
8.1. Asia-Pacific Bioconvergence Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Bioconvergence Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Bioconvergence Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Bioconvergence Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Bioconvergence Market
9.1. China Bioconvergence Market Overview
9.2. China Bioconvergence Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Bioconvergence Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Bioconvergence Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Bioconvergence Market
10.1. India Bioconvergence Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Bioconvergence Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Bioconvergence Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Bioconvergence Market
11.1. Japan Bioconvergence Market Overview
11.2. Japan Bioconvergence Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Bioconvergence Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Bioconvergence Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Bioconvergence Market
12.1. Australia Bioconvergence Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Bioconvergence Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Bioconvergence Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Bioconvergence Market
13.1. Indonesia Bioconvergence Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Bioconvergence Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Bioconvergence Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Bioconvergence Market
14.1. South Korea Bioconvergence Market Overview
14.2. South Korea Bioconvergence Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Bioconvergence Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Bioconvergence Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Bioconvergence Market
15.1. Western Europe Bioconvergence Market Overview
15.2. Western Europe Bioconvergence Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Bioconvergence Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Bioconvergence Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Bioconvergence Market
16.1. UK Bioconvergence Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Bioconvergence Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Bioconvergence Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Bioconvergence Market
17.1. Germany Bioconvergence Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Bioconvergence Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Bioconvergence Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Bioconvergence Market
18.1. France Bioconvergence Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Bioconvergence Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Bioconvergence Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Bioconvergence Market
19.1. Italy Bioconvergence Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Bioconvergence Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Bioconvergence Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Bioconvergence Market
20.1. Spain Bioconvergence Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Bioconvergence Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Bioconvergence Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Bioconvergence Market
21.1. Eastern Europe Bioconvergence Market Overview
21.2. Eastern Europe Bioconvergence Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Bioconvergence Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Bioconvergence Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Bioconvergence Market
22.1. Russia Bioconvergence Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Bioconvergence Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Bioconvergence Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Bioconvergence Market
23.1. North America Bioconvergence Market Overview
23.2. North America Bioconvergence Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Bioconvergence Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Bioconvergence Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Bioconvergence Market
24.1. USA Bioconvergence Market Overview
24.2. USA Bioconvergence Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Bioconvergence Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Bioconvergence Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Bioconvergence Market
25.1. Canada Bioconvergence Market Overview
25.2. Canada Bioconvergence Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Bioconvergence Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Bioconvergence Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Bioconvergence Market
26.1. South America Bioconvergence Market Overview
26.2. South America Bioconvergence Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Bioconvergence Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Bioconvergence Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Bioconvergence Market
27.1. Brazil Bioconvergence Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Bioconvergence Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Bioconvergence Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Bioconvergence Market
28.1. Middle East Bioconvergence Market Overview
28.2. Middle East Bioconvergence Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Bioconvergence Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Bioconvergence Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Bioconvergence Market
29.1. Africa Bioconvergence Market Overview
29.2. Africa Bioconvergence Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Bioconvergence Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Bioconvergence Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Bioconvergence Market Competitive Landscape And Company Profiles
30.1. Bioconvergence Market Competitive Landscape
30.2. Bioconvergence Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Veolia Environnement S.A Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
31. Bioconvergence Market Other Major And Innovative Companies
31.1. Eli Lilly and Company
31.2. Amgen Inc.
31.3. HDR Inc.
31.4. Ginkgo Bioworks
31.5. BICO Group AB
31.6. MeMed Diagnostics Ltd.
31.7. Anima Biotech
31.8. Singota Solutions LLC
31.9. SetPoint Medical Corporation
31.10. Galvani Bioelectronics
31.11. Ezassi Inc.
31.12. Tissue Dynamics Ltd.
31.13. Sanara Ventures Ltd.
31.14. BioConvergent Health LLC
31.15. Gradiant Bioconvergence Center
32. Global Bioconvergence Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Bioconvergence Market
34. Recent Developments In The Bioconvergence Market
35. Bioconvergence Market High Potential Countries, Segments and Strategies
35.1 Bioconvergence Market In 2029 - Countries Offering Most New Opportunities
35.2 Bioconvergence Market In 2029 - Segments Offering Most New Opportunities
35.3 Bioconvergence Market In 2029 - Growth Strategies
